Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.99.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.467EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
CM.8.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BQ.1.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used